Manufacture of pharmaceutical preparations
PHARMAQ AS
Revenue 2024
NOK 2.0bn
Operating profit
NOK 1.2bn
Equity
NOK 4.5bn
Incorporated
2004
Employees
299
Share capital
NOK 17.2m
Key figures · 2024
Current ratio
9.49
Equity ratio
89.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 57.3% | |
| Net margin (%%) | 47.0% | |
| Return on assets (%%) | 23.2% | |
| Likviditet | ||
| Current ratio | 9.49 | |
| Working capital | 4.1bn | |
| Soliditet | ||
| Equity ratio (%%) | 89.4% | |
| Debt-to-equity ratio | 0.12 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.